Obsessive-compulsive disorder: Update on assessment and treatment

Journal of Psychiatric Practice

Volumn 13, Issue 6, 2007, Pages 362-372

  Björgvinsson, Thröstur ^a,b   Hart, John ^b   Heffelfinger, Susan ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MENNINGER CLINIC   (United States)

Author keywords

Assessment; Cognitive behavioral therapy (CBT); Exposure and response prevention (ERP); Obsessive compulsive disorder; Pharmacotherapy; Serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; PAROXETINE; PLACEBO; SERTRALINE;

BEHAVIOR THERAPY; CHECKLIST; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; COMORBIDITY; CULTURAL FACTOR; DISEASE SEVERITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; GENETIC RISK; HUMAN; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PREVALENCE; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOLOGY; RATING SCALE; REVIEW; RISK FACTOR; SELF REPORT; SEMI STRUCTURED INTERVIEW; STRUCTURED INTERVIEW; THERAPY EFFECT; TREATMENT PLANNING; TREATMENT RESPONSE;

ADOLESCENT; BEHAVIOR THERAPY; COMORBIDITY; FEMALE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOLOGICAL TESTS; SEROTONIN UPTAKE INHIBITORS;

EID: 36349001151     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000300122.76322.ad     Document Type: Review

References (79)

1. Abramowitz JS, Houts AC. Concept and controversies in obsessive-compulsive disorder. New York: Springer; 2006.
2. Jenike MA. Theories of etiology. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-compulsive disorder: Practical management, 3rd edition. St. Louis, MO: Mosby; 1998:203-21.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000.
4. Eisen JL, Mancebo MA, Pinto A, et al. Impact of obsessive-compulsive disorder on quality of life. Compr Psychiatry 2006;47:270-5.
5. World Health Organization. The world health report 2001 - Mental health: New understanding, new hope. Geneva, Switzerland: World Health Organization; 2001.
6. Khan A, Leventhal RM, Khan S, et al. Suicide risk in patients with anxiety disorders: A meta-analysis of the FDA database. J Affect Disord 2002;68:183-90.
7. Hollander E. Witches, pumpkins, and other frightful topics. CNS Spectr 2007;10:730-1.
8. Torres AR, Ramos-Cerqueira AT, Torresan RC, et al. Prevalence and associated factors for suicidal ideation and behaviors in obsessive-compulsive disorder. CNS Spectr 2007;12:771-8.
9. Karno M, Golding JM, Sorenson SB, et al. The epidemiology of obsessive-compulsive disorder in five U.S. communities. Arch Gen Psychiatry 1988;45,1094-9.
10. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder (The Cross National Collaborative Group). J Clin Psychiatry 1994;55:5-10.
11. Akhtar S, Wig NN, Varma VK, et al. A phenomenological analysis of symptoms in obsessive-compulsive neurosis. Br J Psychiatry 1975;127:342-8.
12. Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am 1992;15:743-58.
13. Leckman JF, Grice DE, Boardman J, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997;154:911-7.
14. Summerfeldt LJ, Richter MA, Antony MM, et al. Symptom structure in obsessive-compulsive disorder: A confirmatory factor-analytic study. Behav Res Ther 1999;37:297-311.
15. Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005;162:228-38.
16. Mataix-Cols D. Deconstructing obsessive-compulsive disorder: A multidimensional perspective. Curr Opin Psychiatry 2006;19:1984-9.
17. Calamari JE, Cohen RJ, Rector NA, et al. Dysfunctional belief-based obsessive-compulsive disorder subgroups. Behav Res Ther 2006;44:1347-60.
18. Hollander E, Friedberg JP, Wasserman S, et al. The case for the OCD spectrum. In: Abramowitz JS, Houts AC, eds. Concepts and controversies in obsessive-compulsive disorder. New York: Springer; 2005:95-113.
19. Antony MM, Downie F, Swinson RP. Diagnostic issues and epidemiology in obsessive-compulsive disorder. In: Swinson RP, Antony MM, Rachman S, et al., eds. Obsessive-compulsive disorder: Theory, research, and treatment. New York: Guilford; 1998:3-32.
20. Skodol AE, Oldham JM, Hyler SE, et al. Patterns of anxiety and personality disorder comorbidity. J Psychiatr Res 1995;29:361-74.
21. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2004;65:948-58.
22. Pitman RK. Historical considerations. In: Zohar J, Insel TR, Rasmussen SA, eds. The psychobiology of obsessive-compulsive disorder, volume. 4. New York: Springer; 1991:1-12.
23. Gabbard GO. Psychodynamic psychiatry in clinical practice, 4th edition. Washington, DC: American Psychiatric Publishing; 2005.
24. Coles ME, Pinto A, Mancebo MC, et al. OCD with comorbid OCPD: A subtype of OCD? J Psychiatr Res, in press.
25. Eisen J, Coles ME, Shea T, et al. Clarifying the convergence between obsessive-compulsive personality disorder criteria and obsessive-compulsive disorder. J Personal Disord 2006;20:294-305.
26. Di Nardo P, Moras K, Barlow DH, et al. Reliability of DSM-III-R anxiety disorder categories: Using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Arch Gen Psychiatry, 1993;50:251-6.
27. First MB, Spitzer RL, Williams JBW, et al. Structured Clinical Interview for DSM-IV (SCID). Washington, DC: American Psychiatric Association; 1996.
28. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, research version, non-patient edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
29. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale: Pt. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-11.
30. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale: Pt. II. Validity. Arch Gen Psychiatry 1989;46:1012-6.
31. Steketee GS. Treatment of obsessive-compulsive disorder. New York: Guilford; 1993.
32. Steketee GS, Frost R, Bogart K. The Yale-Brown Obsessive Compulsive Scale: Interview versus self-report. Behav Res Ther 1996;34:675-84.
33. Foa EB, Huppert JD, Leiberg S, et al. The Obsessive-Compulsive Inventory: Development and validation of a short version. Psychol Assess 2002;14:485-96.
34. Thordarson DS, Radomsky AS, Rachman S, et al. The Vancouver Obsessional Compulsive Inventory (VOCI). Behav Res Ther 2004;42:1289-1314.
35. Burns GL, Keortge SG, Formea GM, et al. Revision of the Padua Inventory of obsessive compulsive disorder symptoms: distinctions between worry, obsessions, and compulsions. Behav Res Ther 1996;24:163-73.
36. Björgvinsson T, Hart J. Obsessive-compulsive disorder. In: Hersen M, Rosqvist J, eds. Handbook of assessment, conceptualization, and treatment: Volume I, adults. New York: Wiley; 2007 (in press).
37. Mowrer OH. Learning theory and behavior. New York: Wiley; 1960.
38. Salkovskis PM, Forrester E, Richards HC, et al. The devil is in the detail: Conceptualizing and treating obsessional problems. In: Tarrier N, Wells A, Haddock G, eds. Treating complex cases: The cognitive behavioral therapy approach. New York: Wiley; 1998:47-80.
39. Rachman S. A cognitive theory of obsessions. Behav Res Ther 1997;35:793-802.
40. Rachman S. A cognitive theory of obsessions: Elaborations. Behav Res Therapy 1998;36:385-401.
41. Rachman S. Progress toward a cognitive clinical psychology. J Psychosom Res 1998;45:387-9.
42. Clark DA. Cognitive-behavioral therapy for OCD. New York: Guilford; 2004.
43. Salkovskis PM. Obsessional-compulsive problems: A cognitive-behavioral analysis. Behav Res Ther 1985;23:571-83.
44. Salkovskis PM, Forrester E, Richards C. Cognitive-behavioral approach to understanding obsessional thinking. Br J Psychiatry 1998;35(suppl):53-63.
45. Salkovskis PM, Shafran R, Rachman S, et al. Multiple pathways to inflated responsibility beliefs in obsessional problems: Possible origins and implications for therapy and research. Behav Res Ther 1999;37:1055-72.
46. Obsessive Compulsive Cognitions Working Group. Cognitive assessment of obsessive-compulsive disorder. Behav Res Therapy 1997;35:667-81.
47. Wells A. Emotional disorders and metacognitions: Innovative cognitive therapy. Hoboken, NJ: Wiley; 2002.
48. Fisher PL, Wells A. Experimental modification of beliefs in obsessive-compulsive disorder: A test of the metacognitive model. Behav Res Ther 2005;43:821-9.
49. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004;132:69-79.
50. Saxena S, Bota RG, Brody AL. Brain-behavior relationships in obsessive-compulsive disorder. Semin Clin Neuropsychiatry 2001;6:82-101.
51. de Silva P, Marks M. The role of traumatic experiences in the genesis of obsessive-compulsive disorder. Behav Res Ther 1999;37:941-51.
52. Neziroglu F, Anemone R, Yaryura-Tobias J. Onset of obsessive-compulsive disorder in pregnancy. Am J Psychiatry 1992;149:947-50.
53. Abramowitz JS, Nelson CA, Rygwall R, Khandker M. The cognitive mediation of obsessive-compulsive symptoms: A longitudinal study. J Anx Disord 2007;21:91-104.
54. Hanna GL. Clinical and family-genetic studies of childhood obsessive-compulsive disorder. In: Goodman WK, Rudorfer MV, Maser JD, eds. Obsessive-compulsive disorder: Contemporary issues in treatment. Mahwah, NJ: Erlbaum; 2000:133-54.
55. Grados MA, Walkup J, Walford S. Genetics of obsessive compulsive disorders: New findings and challenges. Brain Dev 2003;25:55-61.
56. Nestadt G, Samuels J, Riddle M, et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000;57:358-63.
57. Samuels JF, Riddle MA, Greenberg BD, et al. The OCD Collaborative Genetics Study: Methods and sample description. Am J Med Genet B Neuropsychiatr Genet 2006;141:201-7.
58. Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review. J Consult Clin Psychol 1997;65:44-52.
59. Fisher PL, Wells A. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Beh Res Ther 2005;43:1543-58.
60. Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: Methodological issues, operational definitions and therapeutic lines. Prog Neuro-Psychopharmacol Biol Psychiatry 2006;30:400-12.
61. American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Arlington, VA: American Psychiatric Association, 2007.
62. Rothbaum BO. Virtual reality exposure therapy. In: Rothbaum BO, ed. Pathological anxiety: Emotional processing in etiology and treatment. New York: Guilford; 2006:227-44.
63. Abramowitz JS, Foa EB, Franklin ME. Exposure and ritual prevention for obsessive-compulsive disorder: Effects of intensive versus twice-weekly sessions. J Consult Clin Psychol 2003;71:394-8.
64. Neziroglu F, Henricksen J, Yaryura-Tobias JA. Psychotherapy of obsessive-compulsive disorder and spectrum: Established facts and advances, 1995-2005. Psychiatr Clin North Am 2006;29:585-604.
65. Stanley MA, Turner SM. Current status of pharmacological and behavioral treatment of obsessive compulsive disorder. Behav Ther 1995;26:163-86.
66. Frost RO, Steketee G. Cognitive approaches to obsessions and compulsions: Theory, assessment, and treatment. Oxford: Elsevier; 2002.
67. van Oppen P, de Haan E, van Balkom AJ, et al. Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther 1995;33:379-90.
68. Kozak MJ, Coles ME. Treatment for OCD: Unleashing the power of exposure. In: Abramowitz JS, Houts AC, eds. Concepts and controversies in obsessive-compulsive disorder. New York: Springer; 2005:283-304.
69. Jacobson NS, Roberts LJ, Berns SB, et al. Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives. J Consult Clin Psychol 1999;67:300-7.
70. Franklin ME, Foa E. Cognitive behavioral treatments for obsessive compulsive disorder. In: Nathan PE, Gorman JM, eds. Guides to treatments that work. New York: Oxford University Press; 2002:367-86.
71. Rosqvist J. Exposure treatments for anxiety disorders: A practitioner's guide to concepts, methods and evidence-based practice. New York: Routledge; 2005.
72. Bram T, Björgvinsson T. A psychodynamic clinician's foray into cognitive-behavioral therapy utilizing exposure and ritual prevention for OCD. Am J Psychother 2004;58:304-20.
73. Hayes S, Strosahl KD, Wilson KG. Acceptance and commitment therapy: An experiential approach to behavioral change. New York: Guilford; 1999.
74. Twohig MP, Hayes SC, Masuda A. Increasing willingness to experience obsessions: Acceptance and commitment therapy as a treatment for obsessive-compulsive disorder. Behav Ther 2006;37:3-13.
75. Davidson J, Björgvinsson T. Current and future treatments of obsessive-compulsive-disorder. Expert Opin Investig Drugs 2003;12:993-1001.
76. Dougherty DD, Rauch SL, Jenike MA. Pharmacotherapy for obsessive-compulsive disorder. J Clin Psychol 2004;60:1195-1202.
77. Clomipramine Collaborative Study Group. Clomipramine in the treatment of patient with obsessive-compulsive disorder. Arch Gen Psychiatry, 1991;48:730-8.
78. Skapinakis P, Papatheodorou T, Mavereas V. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: A meta-analysis of the randomized controlled trials. Eur Neuropsychopharmacol 2007;17:79-93.
79. Jenike MA. Clinical practice: Obsessive-compulsive disorder. N Engl J Med 2004;350:259-65.